Beta Bionics (BBNX), a maker of insulin delivery devices, has filed for a $100M initial public offering. While Beta Bionics ...
Glooko’s integration of Hedia’s diabetes tech aims to improve care for patients and enhance healthcare provider insights.
A new study published in the NEJM Evidence journal showed that automated insulin delivery reduced hypoglycemia in older ...
This research and delivery system will help patients with type 1 and type 2 diabetes receive their insulin based on real-time glucose levels.
In a report released today, Lee Hambright from Bernstein maintained a Buy rating on Tandem Diabetes Care (TNDM – Research Report), with a price ...
Glooko and Hedia launched their interoperable solution, combining connected care, remote patient monitoring, and digital therapeutics for diabetes.
Request To Download Free Sample of This Strategic Report @ This country research report on Vietnam Insulin Pumps Market offers comprehensive insights into the market landscape, customer intelligence, ...